As shown in the preclinical study by de Gooijer et al.162, the efficacy in the treatment of brain tumors, even when the tumor reduces the integrity of the BBB, is restricted by ABCB1 and ABCG2. This evidence concerns the gene ABCG2 and neoplasm.